{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:32:16Z","timestamp":1784043136857,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":3406,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1111\/ajt.12328","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T11:58:59Z","timestamp":1373457539000},"page":"2035-2043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["PI3K\u03b4 Inhibition Augments the Efficacy of Rapamycin in Suppressing Proliferation of Epstein\u2212Barr Virus (EBV)+ B Cell Lymphomas"],"prefix":"10.1016","volume":"13","author":[{"given":"S.","family":"Furukawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Krams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.O.","family":"Esquivel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.M.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2 Suppl","key":"10.1111\/ajt.12328_bib1","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1097\/01.tp.0000186382.81130.ba","article-title":"Malignancy after transplantation","volume":"80","author":"Buell","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12328_bib2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/ajt.12137","article-title":"Syk-induced PI3K\/AKT activation in Epstein\u2212Barr virus (EBV+) post-transplant lympoproliferative disorder","volume":"13","author":"Hatton","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12328_bib3","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI44145","article-title":"Next-generation mTOR inhibitors in clinical oncology: How pathway complexity informs therapeutic strategy","volume":"121","author":"Wander","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1111\/ajt.12328_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2012.01.005","article-title":"mTOR inhibitors in cancer therapy","volume":"319","author":"Zaytseva","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1111\/ajt.12328_bib5","first-page":"4472","article-title":"Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein\u2212Barr virus B-cell lymphomas","volume":"63","author":"Nepomuceno","year":"2003","journal-title":"Cancer Res"},{"key":"10.1111\/ajt.12328_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MOT.0b013e3283186ba9","article-title":"Epstein\u2212Barr virus, rapamycin, and host immune responses","volume":"13","author":"Krams","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/ajt.12328_bib7","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1111\/j.1600-6143.2008.02391.x","article-title":"mTOR, cancer and transplantation","volume":"8","author":"Geissler","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12328_bib8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1046\/j.1523-1755.2003.00805.x","article-title":"Rapamycin is an effective inhibitor of human renal cancer metastasis","volume":"63","author":"Luan","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.12328_bib9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1399-0012.2004.00188.x","article-title":"Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: Results from five multicenter studies","volume":"18","author":"Mathew","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1111\/ajt.12328_bib10","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/00007890-200110150-00001","article-title":"Rapamycin: Clinical results and future opportunities","volume":"72","author":"Kahan","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12328_bib11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1681\/ASN.2005090993","article-title":"Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation","volume":"17","author":"Campistol","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.12328_bib12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.TP.0000184006.43152.8D","article-title":"Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies","volume":"80","author":"Kauffman","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12328_bib13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ejca.2012.09.013","article-title":"Risk of de novo cancers after transplantation: Results from a cohort of 7217 kidney transplant recipients, Italy 1997\u22122009","volume":"49","author":"Piselli","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1111\/ajt.12328_bib14","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1600-6143.2007.01972.x","article-title":"Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab","volume":"7","author":"Kirk","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12328_bib15","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1600-6143.2008.02167.x","article-title":"Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids","volume":"8","author":"McDonald","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12328_bib16","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","article-title":"Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression","volume":"80","author":"Caillard","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12328_bib17","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/j.transproceed.2007.05.046","article-title":"Conversion to rapamycin immunosuppression for malignancy after kidney transplantation: Case reports","volume":"39","author":"Iaria","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12328_bib18","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1053\/j.ajkd.2006.01.029","article-title":"Sirolimus-induced remission of posttransplantation lymphoproliferative disorder","volume":"47","author":"Cullis","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/ajt.12328_bib19","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.transproceed.2007.08.078","article-title":"Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies","volume":"39","author":"Boratynska","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12328_bib20","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/01.tp.0000280549.93403.dd","article-title":"Use of everolimus as a rescue immunosuppressive therapy in liver transplant patients with neoplasms","volume":"84","author":"Gomez-Camarero","year":"2007","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"10.1111\/ajt.12328_bib21","doi-asserted-by":"crossref","first-page":"i27","DOI":"10.1093\/ndt\/gfm088","article-title":"Post-transplant lymphoproliferative disorder\u2014The potential of proliferation signal inhibitors","volume":"22","author":"Pascual","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ajt.12328_bib22","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.transproceed.2010.03.051","article-title":"Conversion to rapamycin immunosuppression for malignancy after kidney transplantation","volume":"42","author":"Manuelli","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12328_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/IR:24:2:097","article-title":"Signaling by CD40 and its mimics in B cell activation","volume":"24","author":"Bishop","year":"2001","journal-title":"Immunol Res"},{"key":"10.1111\/ajt.12328_bib24","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2007-05-090142","article-title":"Epstein\u2212Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival","volume":"110","author":"Mancao","year":"2007","journal-title":"Blood"},{"key":"10.1111\/ajt.12328_bib25","doi-asserted-by":"crossref","first-page":"37368","DOI":"10.1074\/jbc.M111.255125","article-title":"Syk activation of phosphatidylinositol 3-kinase\/Akt prevents HtrA2-dependent loss of X-linked inhibitor of apoptosis protein (XIAP) to promote survival of Epstein\u2212Barr virus+ (EBV+) B cell lymphomas","volume":"286","author":"Hatton","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1111\/ajt.12328_bib26","doi-asserted-by":"crossref","first-page":"8225","DOI":"10.4049\/jimmunol.179.12.8225","article-title":"Latent membrane protein 1 of EBV activates phosphatidylinositol 3-kinase to induce production of IL-10","volume":"179","author":"Lambert","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/ajt.12328_bib27","doi-asserted-by":"crossref","first-page":"e42610","DOI":"10.1371\/journal.pone.0042610","article-title":"Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein\u2212Barr virus (EBV)+ B cell lymphomas","volume":"7","author":"Hatton","year":"2012","journal-title":"PLoS ONE"},{"issue":"Suppl 2","key":"10.1111\/ajt.12328_bib28","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1517\/14728222.2011.639361","article-title":"The RAS\/RAF\/MEK\/ERK and the PI3K\/AKT signalling pathways: Role in cancer pathogenesis and implications for therapeutic approaches","volume":"16","author":"De Luca","year":"2012","journal-title":"Expert Opin Therapeutic Targets"},{"key":"10.1111\/ajt.12328_bib29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1128\/MCB.17.1.338","article-title":"A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain","volume":"17","author":"Klippel","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1111\/ajt.12328_bib30","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1073\/pnas.94.9.4330","article-title":"P110delta, a novel phosphoinositide 3-kinase in leukocytes","volume":"94","author":"Vanhaesebroeck","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/ajt.12328_bib31","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1096\/fj.11-198192","article-title":"High levels of p110delta PI3K expression in solid tumor cells suppress PTEN activity, generating cellular sensitivity to p110delta inhibitors through PTEN activation","volume":"26","author":"Tzenaki","year":"2012","journal-title":"FASEB J"},{"issue":"Suppl 3","key":"10.1111\/ajt.12328_bib32","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminoncol.2009.10.011","article-title":"Mammalian target of rapamycin: Discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth","volume":"36","author":"Gibbons","year":"2009","journal-title":"Sem Oncol"},{"key":"10.1111\/ajt.12328_bib33","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","article-title":"mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt","volume":"66","author":"O\u2019Reilly","year":"2006","journal-title":"Cancer Res"},{"key":"10.1111\/ajt.12328_bib34","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.4049\/jimmunol.158.9.4045","article-title":"Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines","volume":"158","author":"Beatty","year":"1997","journal-title":"J Immunol"},{"key":"10.1111\/ajt.12328_bib35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1111\/ajt.12328_bib36","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1111\/ajt.12328_bib37","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1073\/pnas.080068597","article-title":"The immunosuppressive macrolide RAD inhibits growth of human Epstein\u2212Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders","volume":"97","author":"Majewski","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/ajt.12328_bib38","doi-asserted-by":"crossref","first-page":"10963","DOI":"10.1074\/jbc.274.16.10963","article-title":"Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase","volume":"274","author":"Bi","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1111\/ajt.12328_bib39","first-page":"169","article-title":"Early embryonic lethality in mice deficient in the p110beta catalytic subunit of PI 3-kinase","volume":"13","author":"Bi","year":"2002","journal-title":"Mammalian Genome"},{"key":"10.1111\/ajt.12328_bib40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature04694","article-title":"Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation","volume":"441","author":"Foukas","year":"2006","journal-title":"Nature"},{"key":"10.1111\/ajt.12328_bib41","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1084\/jem.20020805","article-title":"A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation","volume":"196","author":"Clayton","year":"2002","journal-title":"J Exp Med"},{"key":"10.1111\/ajt.12328_bib42","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1128\/MCB.22.24.8580-8591.2002","article-title":"Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex","volume":"22","author":"Jou","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1111\/ajt.12328_bib43","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fimmu.2012.00256","article-title":"Selective inhibitors of phosphoinositide 3-kinase delta: Modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies","volume":"3","author":"Puri","year":"2012","journal-title":"Front Immunol"},{"key":"10.1111\/ajt.12328_bib44","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.1158\/0008-5472.CAN-08-1178","article-title":"EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration","volume":"68","author":"Shair","year":"2008","journal-title":"Cancer Res"},{"key":"10.1111\/ajt.12328_bib45","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1182\/blood-2010-02-271171","article-title":"Phosphatidylinositol 3-kinase-delta inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals","volume":"116","author":"Herman","year":"2010","journal-title":"Blood"},{"key":"10.1111\/ajt.12328_bib46","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1182\/blood-2011-10-386763","article-title":"PI3Kdelta inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma","volume":"119","author":"Meadows","year":"2012","journal-title":"Blood"},{"key":"10.1111\/ajt.12328_bib47","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2009-06-222943","article-title":"PI3K\/p110{delta} is a novel therapeutic target in multiple myeloma","volume":"116","author":"Ikeda","year":"2010","journal-title":"Blood"},{"key":"10.1111\/ajt.12328_bib48","article-title":"GS-1101: A delta-specific PI3K inhibitor in chronic lymphocytic leukemia","author":"Macias-Perez","year":"2012","journal-title":"Curr Hematol Malignancy Rep"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.12328","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522260547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522260547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:01:15Z","timestamp":1761627675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522260547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1600613522260547"],"URL":"https:\/\/doi.org\/10.1111\/ajt.12328","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PI3K\u03b4 Inhibition Augments the Efficacy of Rapamycin in Suppressing Proliferation of Epstein\u2212Barr Virus (EBV)+ B Cell Lymphomas","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.12328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}